Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Tonix Pharmaceuticals Holding (TNXP) Leases (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Leases over the past 3 years, most recently at $1.5 million for Q4 2025.

  • Quarterly results put Leases at $1.5 million for Q4 2025, up 173.27% from a year ago — trailing twelve months through Dec 2025 was $1.5 million (up 173.27% YoY), and the annual figure for FY2025 was $1.5 million, up 173.27%.
  • Leases for Q4 2025 was $1.5 million at Tonix Pharmaceuticals Holding, up from $376000.0 in the prior quarter.
  • Over the last five years, Leases for TNXP hit a ceiling of $1.5 million in Q4 2025 and a floor of $376000.0 in Q3 2025.
  • Median Leases over the past 3 years was $660000.0 (2024), compared with a mean of $720750.0.
  • Peak annual rise in Leases hit 173.27% in 2025, while the deepest fall reached 40.13% in 2025.
  • Tonix Pharmaceuticals Holding's Leases stood at $824000.0 in 2023, then plummeted by 31.43% to $565000.0 in 2024, then surged by 173.27% to $1.5 million in 2025.
  • The last three reported values for Leases were $1.5 million (Q4 2025), $376000.0 (Q3 2025), and $438000.0 (Q2 2025) per Business Quant data.